Within the emerging geroscience paradigm 2 , pharmacologic agents originally developed for metabolic indications, such as GLP-1 receptor agonists 3,4,5,6 , have garnered attention due to their potential dual roles in metabolic regulation and aging biology 7
February 3rd, 2025: Ozempic Lawsuit adds 112 cases As of February 2025, the number of Ozempic lawsuit cases reached 1,443, marking an increase of 112 cases from the 1,331 filed in January 2025
In one long-term study, called the SURMOUNT-1 trial, people taking tirzepatide lost up to 25% of their starting weight over a period of 72 weeks
Its primary role includes regulating blood sugar levels by influencing insulin secretion, appetite, and digestion
Its concentration matters, too little and sterility may not be maintained over the full use period, too much and it can interact with the peptide or cause injection site irritation